Related Experiment Video
Updated: Jul 7, 2026
12:54
Real-time Analysis of Transcription Factor Binding, Transcription, Translation, and Turnover to Display Global Events During Cellular Activation
Published on: March 7, 2018
A small molecule transcriptional activation domain
Aaron R Minter1, Brian B Brennan, Anna K Mapp
1Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal of the American Chemical Society
|August 26, 2004
Summary
Researchers developed small organic molecules, isoxazolidines, that mimic natural protein activation domains. These molecules effectively regulate gene transcription, offering potential for new disease therapies.
Area of Science:
- Molecular Biology
- Medicinal Chemistry
- Drug Discovery
Background:
- Transcriptional regulation is crucial for cellular function and implicated in various human diseases.
- Artificial transcriptional activators are valuable tools for studying gene regulation.
- Developing small organic molecules that mimic natural activation domains is a significant challenge.
Purpose of the Study:
- To discover and characterize novel small molecules that function as artificial transcriptional activators.
- To explore the potential of these molecules as therapeutic agents for diseases linked to misregulated transcription.
Main Methods:
- Synthesis of isoxazolidine compounds with diverse polar and hydrophobic functional groups.
- Assay of the synthesized compounds for their ability to mimic natural transcriptional activation domains.
- Evaluation of the potency of the most effective compounds compared to natural domains.
Main Results:
- The study presents the first examples of small organic molecules, specifically isoxazolidines, that mimic transcriptional activation domains.
- The most potent isoxazolidine derivative demonstrated functional activity comparable to natural activation domains.
- These molecules possess an array of polar and hydrophobic functional groups essential for their activity.
Conclusions:
- Isoxazolidines represent a novel class of artificial transcriptional activators.
- These small molecules hold promise for the development of transcription-based therapeutics.
- Further research into isoxazolidines could advance the understanding and treatment of diseases associated with transcriptional dysregulation.
Related Concept Videos
02:57DNA-only Transposons
DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
The donor site from where the transposon is excised is either degraded or...
02:26tRNA Activation
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
02:40The Eukaryotic Promoter Region
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
02:42Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
02:26tRNA Activation
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
02:40The Eukaryotic Promoter Region
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...